Duncker Streett & CO Inc Humacyte, Inc. Transaction History
Duncker Streett & CO Inc
- $532 Million
- Q4 2024
A detailed history of Duncker Streett & CO Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Duncker Streett & CO Inc holds 800 shares of HUMA stock, worth $3,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800Holding current value
$3,215% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
160Shares Held
36.4MCall Options Held
284KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$22.5 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$19.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$8.58 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.1 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $414M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...